Dietary selenium for the mitigation of radiation injury: Effects of selenium dose escalation and timing of supplementation

Radiation Research

Volumn 176, Issue 3, 2011, Pages 366-374

  Sieber, Fritz ^a   Muir, Sarah A ^a   Cohen, Eric P ^b   Fish, Brian L ^a   Mder, Marylou ^a   Schock, Ashley M ^a   Althouse, Bryan J ^a   Moulder, John E ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELENOMETHIONINE; SODIUM SELENITE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG TOLERABILITY; HISTOPATHOLOGY; KIDNEY FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIATION NEPHROPATHY; RAT; UREA NITROGEN BLOOD LEVEL; WHOLE BODY RADIATION;

ANIMALS; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; RADIATION INJURIES; RATS; SELENIUM;

RATTUS;

EID: 80052159464     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2456.1     Document Type: Article

References (27)

1. Sieber F, Muir SA, Cohen EP, North PE, Fish BL, Irving AA, et al. High-dose selenium for the mitigation of radiation injury: a pilot study in a rat model. Radiat Res 2009; 171:368-73.
2. Stone HB, Moulder JE, Coleman CN, Ang KK, Anscher MS, Barcellos-Hoff MH, et al. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI workshop, December 3-4, 2003. Radiat Res 2004; 162:711-28. (Pubitemid 39552901)
3. Cohen EP, Fish BL, Sharma M, Li XA, Moulder JE. Role of angiotensin II type-2 receptor in radiation nephropathy. Trans Res 2007; 150:106-15. (Pubitemid 47081451)
4. Abrams RA, Buck P, Fish BL, Moulder JE. Relationship of cell dose and freezing rate to reconstitute potency in a hematopoietic reconstitution model. Transplantation 1986; 43:581-3. (Pubitemid 17065722)
5. Moulder JE, Fish BL. Late toxicity of total body irradiation with bone marrow transplantation in a rat model. Int J Radiat Oncol Biol Phys 1989; 16:1501-9. (Pubitemid 19154336)
6. Cohen EP, Fish BL, Moulder JE. The renin-angiotensin system in experimental radiation nephropathy. J Lab Clin Med 2002; 139:251-7. (Pubitemid 34557360)
7. McAdam PA, Levander OA. Chronic toxicity and retention of dietary selenium fed to rats as D-or L-selenomethionine, selenite, or selenate. Nutr Res 1987; 7:601-10. (Pubitemid 17093549)
8. Whanger P, Vendeland S, Park YC, Xia Y. Metabolism of subtoxic levels of selenium in animals and humans. Ann Clin Lab Sci 1996; 26:99-113. (Pubitemid 26080703)
9. Moulder JE, Fish BL, Holcenberg JS, Sun GX. Hepatic function and drug pharmacokinetics after total body irradiation plus bone marrow transplant. Int J Radiat Oncol Biol Phys 1990; 19:1389-96.
10. Geraci JP, Mariano MS. Radiation hepatology of the rat: parenchymal and nonparenchymal cell injury. Radiat Res 1993; 136:205-13. (Pubitemid 24004685)
11. Baker JE, Fish BL, Su J, Haworth ST, Strande JL, Komorowski RA, et al. 10 Gy total body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model. Int J Radiat Biol 2009; 85:1089-100.
12. Zhao W, Robbins ME. Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr Med Chem 2009; 16:130-43.
13. Hatfield DL, Berry MJ, Gladyshev VN, editors. Selenium. its molecular biology and role in human health. New York: Springer; 2006.
14. Gä rtner R, Albrich W, Angstwurm MW. The effect of a selenium supplementation on the outcome of patients with severe systemic inflammation, burn and trauma. Biofactors 2001; 14:199-204.
15. Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, et al. Selenium in intensive care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007; 35: 118-26. (Pubitemid 46035686)
16. Gladyshev VN. Selenoproteins and selenoproteomes. In: Hatfield DL, Berry MJ, Gladyshev VN, editors. Selenium. its molecular biology and role in human health. New York: Springer; 2006. pp. 99-110.
17. Sunde RA. Regulation of glutathione peroxidase-1 expression. In: Hatfield DL, Berry MJ, Gladyshev VN, editors. Selenium. its molecular biology and role in human health. New York: Springer 2006. 149-160.
18. Kauf E, Fuchs D, Winnefeld K, Herrmann J, Zintl F. Blood selenium after conditioning and in the course of bone marrow transplantation of children with malignant diseases. Med Klin 1997; 92 Suppl 3:46-7. (Pubitemid 27404620)
19. Hadjibabaie M, Iravani M, Shamshiri AR, Zaker Z, Mousavi A, Alimoghaddam K, et al. The prevalence of low selenium levels in adult patients undergoing bone marrow transplantation: a brief communication. Nutr Cancer 2008; 60:837-9.
20. Fraunholz I, Eberlein K, Schopohl B, Bö ttcher HD, Rö del C. Selenium levels during the course of radiotherapy. No influence of irradiation on blood selenium concentration. Strahlenther Onkol 2008; 184:411-5.
21. Surai PF. Selenium in nutrition and health. Nottingham: Nottingham University Press; 2006.
22. Weiss JF, Landauer MR. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology 2003; 189:1-20. (Pubitemid 36725020)
23. Gehrisch A, Dö rr W. Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa. Strahlenther Onkol 2007; 183:36-42. (Pubitemid 46144103)
24. Muecke R, Schomburg L, Glatzel M, Berndt-Skorka R, Baaske D, Reichl B, et al. Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology. Int J Radiat Oncol Biol Phys 2010; 78:828-35.
25. Cohen EP, Robbins ME. Radiation nephropathy. Semin Nephrol 2003; 23:486-99. (Pubitemid 37176694)
26. Halverson AW, Tsay DT, Triebwasser KC, Whitehead EI. Development of hemolytic anemia in rats fed selenite. Toxicol Appl Pharmacol 1970; 17:151-9.
27. O'Toole D, Raisbeck MF. Pathology of experimentally induced chronic selenosis (alkali disease) in yearling cattle. J Vet Diagn Invest 1995; 7:364-73.